Replies to post #120164 on Innovation Pharmaceuticals Inc (IPIX)

[TOB]

My personal guess is the lion's share of those were sold during the several month CTIX decline that started when the shares came off of restriction. By MAY the selling pressure eased and CTIX ran sideways.

Then a rally leg, so no selling ceiling. Then Biotechs in general started to drift down. Most I watch did the same as CTIX. Of course, CTIX got an extra push from the hit pieces, despite all their falsehoods. But I reckon the biotech sell-off was a big factor.

I note that the Biotech ETF IBB had a rally leg and then started its decline on 7/21, just like CTIX which had a rally leg and then started its decline on 7/21 . Both declined below support after the rally leg.

Compare and contrast the below charts.

(CTIX daily, click to enlarge)


(Biotech ETF IBB daily, click to enlarge)

[TOB]

Also, there will be a six month lock-up period after the next transfer.

I think it would be reasonable to expect him to be much more selective in selling the remaining 6 million when he receives those. -F1ash

We'll know when the transfer takes place from the Form 4. It's been speculated that the transfer will not be before January 2016 to put it into that tax year. Sounds like a reasonable guess to me as there have been no additional transfers.

Should be a whole new CTIX ball game here very soon with the Kevetrin Phase 1 clinical trial at Dana Farber wrapping up. A lock for a positive primary outcome measure of safety, and we can expect to hear top-line data on secondary outcome measures designed to show indications of efficacy.

CTIX

[warrenthomas4001]

Agree totally.


"With 10 million between the lawyers and Aruda hopefully that $0 cost basis supply is getting close to being exhausted. That would only leave Aspire who will have a much higher cost basis.

I think it would be reasonable to expect him to be much more selective in selling the remaining 6 million when he receives those."